14-3-3 proteins play important roles in the cell cycle (68) and targeting YWHAH (14-3-3 eta) to enhance mitotic cell death presents a potential therapeutic strategy to overcome radioresistance in glioblastoma (69). Here, YWHAQ is linked to glioblastoma.